Session Details

N001 Celebrating Excellence: A Duo of Distinguished Talks

Fri, Aug 2, 9:00 AM - 10:00 AM
Ballroom 6A
1 CME Available Named Lectureship
View Map

DESCRIPTION

Join us as we recognize and celebrate the exceptional contributions of two distinguished dermatologists to the field of skin health. In this special lecture event, we will honor their remarkable achievements with prestigious awards that reflect their dedication, innovation, and profound impact on dermatology.

SCHEDULE

4:00 PM

Introduction of Fox Award Winner

Howard Wooding Rogers, MD, PhD, FAAD

4:05 PM

Fox Award Lecture: Focusing on permanencies amidst innovation

Warren R. Heymann, MD, FAAD

4:30 PM

Introduction of Kelly Award Winner

Howard Wooding Rogers, MD, PhD, FAAD

4:35 PM

Kelly Award Lecture: Illuminating the Spectrum of Skin of Color: Clinical challenges, therapeutic advances, and future directions

Andrew F. Alexis, MD, MPH, FAAD

SPEAKERS

Andrew F. Alexis, MD, MPH, FAAD

Andrew F. Alexis, MD, MPH, FAAD

Weill Cornell Medicine

Warren R. Heymann, MD, FAAD

Warren R. Heymann, MD, FAAD

Howard Wooding Rogers, MD, PhD, FAAD

Howard Wooding Rogers, MD, PhD, FAAD

SPEAKER DISCLOSURES

Andrew F. Alexis, MD, MPH, FAAD

AbbVie – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); Aerolase – Other(Equipment); Allergan, Inc. – Advisory Board(Honoraria); Almirall – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Alphyn Biologics – Advisory Board(Honoraria); Amgen – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); Apogee BioPharm – Advisory Board(Honoraria); Arcutis Biotherapeutics – Investigator(Grants/Research Funding); Arcutis, Inc. – Advisory Board(Honoraria); Astra Zeneca – Advisory Board(Honoraria); Bausch Health – Advisory Board(Honoraria); Beiersdorf, Inc. – Advisory Board(Honoraria); Boehringer Ingelheim – Consultant (1099 relationship)(Honoraria); Bristol-Myers Squibb – Advisory Board(Fees), Speaker(Honoraria); Canfield Scientific, Inc. – Consultant (1099 relationship)(Fees); Castle Biosciences – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Dermavant Sciences – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Dermavant Sciences, Inc. – Advisory Board(Honoraria); Eli Lilly – Consultant(Fees); Eli Lilly and Company – Advisory Board(Honoraria); Elsevier Inc. – Other(Other Financial Benefit); Foundation for Research & Education of Dermatology – Advisory Board(Honoraria); Galderma Laboratories, L.P. – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); Genentech, Inc. – Advisory Board(Honoraria); Incyte – Advisory Board(Honoraria), Speaker(Honoraria); janssen – Consultant (1099 relationship)(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria); Janssen Scientific Affairs, LLC – Consultant(Honoraria); Johnson and Johnson – Speaker(Honoraria); L'Oréal France – Advisory Board(Honoraria), Speaker(Honoraria); L'Oreal USA Inc. – Advisory Board(Honoraria), Consultant(Fees), Speaker(Honoraria); Leo Pharma Inc – Consultant(Fees); Leo Pharma Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Medscape – Other(Honoraria); Novartis – Advisory Board(Honoraria); OptiNose Inc. – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Fees), Advisory Board(Honoraria), Speaker(Honoraria); RBC Consultants – Advisory Board(Honoraria); Regeneron – Advisory Board(Honoraria); Sanofi Genzyme – Advisory Board(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria), Speaker(Honoraria), Speaker/Faculty Education(Honoraria); Sanova Works – Speaker(Honoraria); Springer Science & Business Media – Other(Other Financial Benefit); Swiss American – Advisory Board(Honoraria); Symrise – Consultant (1099 relationship)(Fees); UCB – Advisory Board(Fees); UpToDate, Inc. – Other(Other Financial Benefit); VisualDx – Advisory Board(Honoraria); Wiley-Blackwell – Other(Other Financial Benefit);

Warren R. Heymann, MD, FAAD

No financial relationships exist with ineligible companies.

Howard Wooding Rogers, MD, PhD, FAAD

No financial relationships exist with ineligible companies.